Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated significant efficacy in treatment of binge-eating disorder (BED). We n...
Background: In a previous flexible dose study, dasotraline, a long-acting dopamine/ norepinephrine reuptake inhibitor, demonstrated significant efficacy in the treatment of binge-eating d...
Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated efficacy in the treatment of binge-eating disorder (BED). We now repor...
Objective: To evaluate the long-term safety and efficacy of lurasidone in children and adolescents with bipolar depression.
Methods: Patients (10-17 years) with bipolar depression who co...
Objective: To obtain long-term data on the safety and effectiveness of lurasidone in adolescents with schizophrenia
Methods: Adolescents (13-17 years) who completed 6 weeks of double-bli...
Objective: To evaluate the efficacy of dasotraline in the treatment of secondary behavioral and psychological outcomes in patients with Binge-eating disorder (BED).
Objective: The aim of the current study was to evaluate the long-term safety and effectiveness of lurasidone in pediatric bipolar depression.
Method: Patients 10-17 years with bipolar I ...